D-0035-2020 Class I Terminated

Recalled by Shire Human Genetic Therapies, Inc. — Lexington, MA

Recall Details

Product Type
Drugs
Report Date
October 2, 2019
Initiation Date
September 12, 2019
Termination Date
March 23, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,556

Product Description

Natpara (parathyroid hormone) for Injection, 25 mcg/dose, 2 pack cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0202-02

Reason for Recall

Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing

Distribution Pattern

Product was distributed throughout the United States.

Code Information

08569357, exp 4/30/2020; 07983652, 08544833, exp 6/30/2021